NCT03671889: ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease
- State
- Under way
- Phase
- No phase
- People
- 50 planned
- Started
- 28 Sep 2018
- Primary completion
- Jan 2028
- Arms
- Blood Brain Barrier (BBB) Disruption
- Results
- None posted
- 14 Sep 2018: Trial registered
- 28 Sep 2018: Trial started